C. Goso

发表

Nuclear factor‐κB, induced in human carcinoma cell line A2780 by the new anthracycline men 10755, is devoid of transcriptional activity

G. Camarda, M. Binaschi, C. Maggi, 2002, International journal of cancer.

Expression and characterization of biologically active human fas ligand produced in CHO cells

C. Maggi, C. Goso, G. Raucci, 2003, Molecular biotechnology.

Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231

C. Maggi, C. Goso, M. Bigioni, 2005, Anti-cancer drugs.

Apoptotic events in a human ovarian cancer cell line exposed to anthracyclines.

C. Maggi, C. Goso, A. Bullo, 2001, The Journal of pharmacology and experimental therapeutics.

Regulation of cytokine production in aging: use of recombinant cytokines to upregulate mitogen-stimulated spleen cells

D. Frasca, P. Barattini, G. Doria, 1997, Mechanisms of Ageing and Development.

Anthracyclines: selected new developments.

G. Capranico, M. Binaschi, C. Maggi, 2001, Current medicinal chemistry. Anti-cancer agents.

Involvement of nitric oxide in both central and peripheral haemodynamic effect of D/L-nebivolol and its enantiomers in rats.

M. Binaschi, C. Maggi, C. Goso, 2005, European journal of pharmacology.

Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties.

C. Maggi, C. Goso, P. Rovero, 1993, The Journal of pharmacology and experimental therapeutics.

MEN15658: a new promising anti-tumoral drug active on resistant tumor cells

G. Camarda, M. Binaschi, C. Maggi, 2004, Anti-cancer drugs.

Sensory Nerves and Tachykinins

C. Goso, A. Szallasi, S. Manzini, 2017 .

Changes in the amount and level of phosphorylation of p56lck in PBL from aging humans

D. Frasca, C. Bartoloni, L. Guidi, 1998, Mechanisms of Ageing and Development.

Cell proliferation and ku protein expression in ageing humans

D. Frasca, P. Barattini, L. Guidi, 1998, Mechanisms of Ageing and Development.

Chronic cardiotoxicity of anticancer anthracyclines in the rat: role of secondary metabolites and reduced toxicity by a novel anthracycline with impaired metabolite formation and reactivity

C. Maggi, C. Goso, S. Manzini, 2003, British journal of pharmacology.

Vanilloid receptors in the urinary bladder: regional distribution, localization on sensory nerves, and species-related differences

C. Goso, P. Blumberg, A. Szallasi, 1993, Naunyn-Schmiedeberg's Archives of Pharmacology.

Resiniferatoxin-induced loss of vanilloid receptors is reversible in the urinary bladder but not in the spinal cord of the rat

C. Goso, A. Szallasi, Gilberto Piovacari, 1993, Neuroscience Letters.

Topical capsaicin administration protects against trinitrobenzene sulfonic acid-induced colitis in the rat.

C. Goso, P. Blumberg, A. Szallasi, 1993, European journal of pharmacology.

Characterization by [3H]resiniferatoxin binding of a human vanilloid (capsaicin) receptor in post-mortem spinal cord

C. Goso, A. Szallasi, 1994, Neuroscience Letters.

Capsaicin‐induced relaxation in the rat isolated external urethral sphincter: characterization of the vanilloid receptor and mediation by CGRP

C. Goso, A. Szallasi, M. Parlani, 1993, British journal of pharmacology.

[3H][beta-Ala8]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK2 receptor.

C. Goso, M. Parlani, S. Manzini, 1995, European journal of pharmacology.

Resiniferatoxin binding to vanilloid receptors in guinea pig and human airways.

C. Goso, A. Szallasi, S. Manzini, 1995, American journal of respiratory and critical care medicine.

Human and murine macrophages mediate activation of MEN 4901/T-0128: a new promising camptothecin analogue–polysaccharide conjugate

M. Binaschi, C. Maggi, C. Goso, 2006, Anti-cancer drugs.

Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat.

C. Maggi, C. Goso, M. Bigioni, 2001, European journal of pharmacology.

Forces determining the adsorption of a monoclonal antibody onto an aluminium hydroxide adjuvant: influence of interstitial fluid components.

C. Goso, Jens Flemming, C. Müller-Goymann, 2009, Vaccine.

NF-kappaB activation contributes to anthracycline resistance pathway in human ovarian carcinoma cell line A2780.

G. Camarda, M. Binaschi, C. Maggi, 2005, International journal of oncology.

Novel anthracycline oligosaccharides: influence of chemical modifications of the carbohydrate moiety on biological activity.

M. Binaschi, C. Maggi, C. Goso, 2002, Bioorganic & medicinal chemistry.

Effect of synthetic thymic humoral factor (THF‐γ2) on T cell activities in immunodeficient ageing mice

D. Frasca, G. Doria, C. Goso, 1992, Clinical and experimental immunology.

A comparative study of cellular and molecular pharmacology of doxorubicin and MEN 10755, a disaccharide analogue.

F. Zunino, G. Capranico, C. Maggi, 2001, Biochemical pharmacology.

MEN 10,627, a novel polycyclic peptide antagonist of tachykinin NK2 receptors.

C. Maggi, C. Goso, C. Pedone, 1994, The Journal of pharmacology and experimental therapeutics.

Sabarubicin- (MEN 10755) and paclitaxel show different kinetics in nuclear factor-kappaB (NF-kB) activation: effect of parthenolide on their cytotoxicity.

M. Binaschi, C. Maggi, C. Goso, 2005, Anticancer research.

Maintenance therapy in ovarian cancer: Molecular basis and therapeutic approach.

M. Binaschi, C. Maggi, C. Goso, 2011, Experimental and therapeutic medicine.

CD137 and CD137 ligand constitutively coexpressed on human T and B leukemia cells signal proliferation and survival

M. Binaschi, C. Maggi, C. Goso, 2004, International journal of cancer.

Synthesis and biological evaluation of novel NK‐1 tachykinin receptor antagonists: The use of cycloalkyl amino acids as a template

A. Sisto, C. Maggi, C. Goso, 1995, Biopolymers.

Different susceptibility to neurokinin 1 receptor antagonists of substance P and septide-induced interleukin-6 release from U373 MG human astrocytoma cell line

C. Goso, C. Palma, S. Manzini, 1994, Neuroscience Letters.

Synthesis and Biological

A. Sisto, C. Maggi, C. Goso, 2003 .

Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.

C. Maggi, C. Goso, M. Astolfi, 1995, The Journal of pharmacology and experimental therapeutics.

Competitive inhibition by capsazepine of [3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder and airways) vanilloid (capsaicin) receptors in the rat.

C. Goso, P. Blumberg, A. Szallasi, 1993, The Journal of pharmacology and experimental therapeutics.

Characterization of a peripheral vanilloid (capsaicin) receptor in the urinary bladder of the rat.

C. Goso, P. Blumberg, A. Szallasi, 1993, Life sciences.